PuraPharm Corporation Limited (1498.HK)
HKD 0.55
(-3.51%)
HKD 0.55
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 53.97 Million | 65.84 Million | -39.32 Million | 86.68 Million | 101.93 Million | 72.46 Million |
| Net Income | -106.08 Million | -120.21 Million | -121.87 Million | 31.71 Million | -227.25 Million | 20.8 Million |
| Depreciation & Amortization | 48.59 Million | 48.66 Million | 50.13 Million | 47.62 Million | 66.75 Million | 35.59 Million |
| Deferred income taxes | -27.91 Million | 4.59 Million | -134.8 Million | -83.1 Million | -11.24 Million | 5.44 Million |
| Stock-based compensation | 4.29 Million | 268 Thousand | 3.5 Million | 5.64 Million | 4.22 Million | 2.11 Million |
| Change in working capital | 62.01 Million | 81.17 Million | -113.24 Million | 20.2 Million | 103.72 Million | -7.55 Million |
| Other non-cash items | 73.06 Million | 51.37 Million | 276.95 Million | 64.59 Million | 165.74 Million | 16.06 Million |
| Investing Cash Flow | -22.29 Million | -25.44 Million | -3.66 Million | -82.16 Million | -75.34 Million | -36.08 Million |
| Investments in PPE | -21.66 Million | -23.55 Million | -6.55 Million | -82.84 Million | -96.95 Million | -45.19 Million |
| Acquisitions | -630 Thousand | 96 Thousand | 2.89 Million | 677 Thousand | - | 91 Thousand |
| Investment purchases | -630 Thousand | -1.98 Million | - | - | -9 Million | -11.77 Million |
| Sales/Maturities of investments | - | - | - | - | - | 11.68 Million |
| Other Investing Activities | 4.08 Million | 1000.00 | 9.67 Million | -9.94 Million | 30.61 Million | 9.1 Million |
| Financing Cash Flow | -96.75 Million | -12.93 Million | 8.77 Million | 29.55 Million | -49.98 Million | -28.02 Million |
| Debt repayment | -73.02 Million | -6.82 Million | -44.67 Million | -32.58 Million | -18.9 Million | -548.9 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 803 Thousand | - | 98.04 Million | -361 Thousand | - |
| Other Financing Activities | -35.13 Million | -6.91 Million | 53.44 Million | -35.9 Million | -30.71 Million | 520.88 Million |
| Accounts receivables | 52.92 Million | 101.28 Million | -43.93 Million | 7.96 Million | 48.67 Million | -56.34 Million |
| Accounts payables | 10.46 Million | 9.6 Million | -22.56 Million | -29.62 Million | 44.41 Million | 30.88 Million |
| Inventory | 10.17 Million | -8.71 Million | 35.47 Million | 39.45 Million | 33.39 Million | 48.79 Million |
| Other working capital | -11.54 Million | -21 Million | -82.22 Million | 2.41 Million | -22.76 Million | -30.88 Million |
| Cash at beginning of period | 107.01 Million | 85.05 Million | 126.45 Million | 93.12 Million | 113.88 Million | 86.8 Million |
| Cash at end of period | 47.22 Million | 107.01 Million | 85.05 Million | 126.45 Million | 93.12 Million | 90.51 Million |
| Capital Expenditure | -21.66 Million | -23.55 Million | -6.55 Million | -82.84 Million | -96.95 Million | -45.19 Million |
| Effect of forex changes on cash | 5.28 Million | -5.5 Million | 6.24 Million | 1.25 Million | -580 Thousand | -4.63 Million |
| Net cash flow / Change in cash | -59.79 Million | 21.96 Million | -41.4 Million | 33.33 Million | -20.76 Million | 3.71 Million |
| Free Cash Flow | 32.31 Million | 42.29 Million | -45.88 Million | 3.83 Million | 4.97 Million | 27.26 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.68 Million | -68.4 Million | -106.08 Million | -37.67 Million | -120.21 Million | -80.31 Million |
| Depreciation & Amortization | 21.69 Million | 27.2 Million | 48.59 Million | 21.38 Million | 48.66 Million | 20.35 Million |
| Deferred income taxes | - | -33.98 Million | -27.91 Million | 6.07 Million | 4.59 Million | -21.13 Million |
| Stock-based compensation | 725 Thousand | 2.14 Million | 4.29 Million | 2.14 Million | 268 Thousand | 102 Thousand |
| Change in working capital | 27.84 Million | 43.02 Million | 62.01 Million | 18.99 Million | 81.17 Million | 27.02 Million |
| Other non-cash items | 11.55 Million | 72.52 Million | 73.06 Million | 538 Thousand | 51.37 Million | 58.75 Million |
| Investing Cash Flow | -6.69 Million | -17.22 Million | -22.29 Million | -5.06 Million | -25.44 Million | -13.43 Million |
| Investments in PPE | -875 Thousand | -17.22 Million | -21.66 Million | -4.43 Million | -23.55 Million | -8.74 Million |
| Acquisitions | - | -1000.00 | -630 Thousand | 1000.00 | 96 Thousand | -812 Thousand |
| Investment purchases | - | - | -630 Thousand | -630 Thousand | -1.98 Million | -1.98 Million |
| Sales/Maturities of investments | - | - | - | 4.99 Million | - | -1.88 Million |
| Other Investing Activities | -5.82 Million | 5.97 Million | 4.08 Million | -4.99 Million | 1000.00 | 1000.00 |
| Financing Cash Flow | -32.42 Million | -61.16 Million | -96.75 Million | -35.58 Million | -12.93 Million | 68.75 Million |
| Debt repayment | -15.57 Million | -47.53 Million | -73.02 Million | -25.49 Million | -6.82 Million | -86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 803 Thousand | - |
| Other Financing Activities | -16.84 Million | 354 Thousand | -35.13 Million | -354 Thousand | -6.91 Million | -5.7 Million |
| Accounts receivables | 18.54 Million | 716 Thousand | 52.92 Million | 52.2 Million | 101.28 Million | 17.79 Million |
| Accounts payables | -4.47 Million | -165 Thousand | 10.46 Million | 10.63 Million | 9.6 Million | -6.45 Million |
| Inventory | 27.03 Million | 22.02 Million | 10.17 Million | -11.85 Million | -8.71 Million | 8.33 Million |
| Other working capital | -17.73 Million | 20.45 Million | -11.54 Million | -31.99 Million | -21 Million | 7.35 Million |
| Cash at beginning of period | 47.22 Million | 82.62 Million | 107.01 Million | 107.01 Million | 85.05 Million | 56.54 Million |
| Cash at end of period | 22.82 Million | 47.22 Million | 47.22 Million | 82.62 Million | 107.01 Million | 107.01 Million |
| Capital Expenditure | -875 Thousand | -17.22 Million | -21.66 Million | -4.43 Million | -23.55 Million | -8.74 Million |
| Effect of forex changes on cash | -1.3 Million | 478 Thousand | 5.28 Million | 4.8 Million | -5.5 Million | -9.64 Million |
| Net cash flow / Change in cash | -24.39 Million | -35.4 Million | -59.79 Million | -24.39 Million | 21.96 Million | 50.46 Million |
| Free Cash Flow | 42.25 Million | 25.29 Million | 32.31 Million | 7.02 Million | 42.29 Million | -3.95 Million |
002936
600615
BC
AMLTF
2612
APXYY